On 15 May the FDA Center for Biologics Evaluation and Research/Office of Blood Research and Review (CBER/OBRR) granted market clearance to the OraQuick in-home HIV-1/2 antibody test based on the recommendation of the Blood Products Advisory Committee.
The U.S. Food and Drug Administration (FDA) recently issued an alert on the potential risk of non-convulsive status epilepticus associated with the use of cefepime, a broad spectrum fourth generation cephalosporin.
FoodNet is an active surveillance program that collects data on 9 laboratory-confirmed pathogens from 10 sites in the United States: 7 states (Connecticut, Georgia, Maryland, Minnesota, New Mexico, Oregon, and Tennessee) and certain counties in California, Colorado, and New York.
In this issue: Lorcaserin for weight loss; statins and fatigue; treatment-resistant gonorrhea; hydrocodone classification changes; USPSTF recommendations; and FDA actions.
A total of 1745 infants from 17 sites in Brazil (70.1%), South Africa (27.4%), Argentina (1.6%) and the United States (0.8%) born to women with a peripartum diagnosis of HIV type I infection were randomized within 48 hours of birth to receive one of three six-week postpartum antiretroviral regimens.
This ProMED-mail alert describes the case of a young Rhode Island resident who traveled to Cambodia and Viet Nam, where she was hospitalized with spinal cord compression in December 2011.
The medical community appears to be deeply divided over a federal recommendation that would push the health system toward mandatory flu shot policies for health care workers.
After considerable controversy that included strong objections by the nation's leading occupational health agency, a federal vaccine committee has approved a recommendation that health care facilities strongly consider mandatory flu immunization of workers if voluntary efforts fail to achieve high vaccination rates.
To examine the association between being placed in contact isolation and delirium, Day and colleagues at the University of Maryland Medical Center reviewed administrative data on all patients admitted during a 2-year period ending in 2009.
State health departments are becoming vital partners with the Centers for Disease Control and Prevention in an increasing national effort to eradicate healthcare associated infections (HAIs).
